XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells - Wikidata - awgldk - TriplyDB

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

http://www.wikidata.org/entity/Q36371312

about

Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263.Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella.High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.Minute kinetics of proapoptotic proteins: BAX and Smac/DIABLO in living tumor cells revealed by homeostatic confocal microscopy.Novel therapies for Hodgkin Lymphoma.Role of Smac/DIABLO in cancer progression.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.Inhibitor of apoptosis proteins in hematological malignancies.Cyclin-dependent kinases regulate apoptosis of intestinal epithelial cells.CD30: an important new target in hematologic malignancies.Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).Key regulators of apoptosis execution as biomarker candidates in melanoma Dimethylfumarate induces apoptosis in human mast cells.Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing.Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6.Essential role of TAK1 in regulating mantle cell lymphoma survival.Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.Heat stress triggers apoptosis by impairing NF-kappaB survival signaling in malignant B cells.Downregulation of xIAP expression by small interfering RNA inhibits cellular viability and increases chemosensitivity to methotrexate in human hepatoma cell line HepG2.Varying Dietary Levels of Molybdenum Inducing Cell Apoptosis of Spleen Under Cadmium Stress in Caprine.Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.Elevated XIAP expression alone does not confer chemoresistance.Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein The role of apoptosis in the pathology of pancreatic cancer STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.Immunocytochemical detection of XIAP in body cavity effusions and washes.Dissociation of Caspase-3 from SMAC:XIAP:Caspase-3 Analysis of NF-κB Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study

P2860

Q24298097-A70EB5E4-738F-417C-8B48-24AE6254509E Q33415723-92BAEB9D-0558-4E40-B6A7-132D822A9213 Q33571656-A45FA027-72E9-4E16-99AE-CBFB22239A73 Q33886267-6D0B8EDE-2FED-43B7-9B1D-74F1CE646A59 Q34480682-6BC51357-A6FB-4055-A815-2ED9D8DC14CD Q34806506-E28FADFA-4D70-4F53-A07E-2F5A3F5B0C37 Q35782071-99BF020A-75BA-49B8-877A-7E020072C948 Q35905166-FE24B28C-2831-4B68-841C-AC446F47C951 Q35922424-10279B4B-9ED0-4DC3-A64F-7CBF6C2F6714 Q36256139-3FF36751-921F-4B13-AEE7-2025CD6FF1A9 Q36612532-DB0E1B61-043E-4A72-A208-5AFE65DC5E12 Q36934716-09DE81C3-F3DC-4B10-BAC2-0065C01D251B Q37004635-5C832E71-BBC6-43E4-B916-AED0CA06DB38 Q37016499-82AC035F-EC52-45B3-A4F4-5B5A5C459911 Q37271829-CFF983BF-112D-4467-83A6-B7C0E6D21B3D Q37336610-419B7B72-1548-4074-94BF-C72180008644 Q37622948-27B5C91F-AED4-46D0-8B07-77F0DA5EFF0D Q37880873-69B78651-0C6F-4E76-927D-9D33EEE52132 Q37974461-F7804308-9B9D-4AC4-B9F8-896966188279 Q38184343-1064FBBC-C3BA-45E2-9049-97571A4066ED Q38217477-5C4F00BA-FE8D-410B-8C7C-A20DE1C7AE72 Q38866722-16FFEEDC-3AAA-4D74-96E7-F00D0310F7A8 Q39083128-4451B6F3-8AEC-4D31-8A16-FE7E56136FE8 Q39148654-44BEB97F-BB28-4CBA-839B-DD9E53720C2B Q39251334-AC7AC75E-EF86-4B61-A986-4EABA9440563 Q39339382-DDF931C6-D779-49A9-9FAC-FE5FEF00E7F4 Q39467184-7615FF05-BA3D-4D36-8EFA-81B8AEEFAE6D Q39772932-D71B3F3F-694E-42F4-93B8-9B3634ABB0D8 Q40204261-C24F077B-8396-47EB-88B8-A33AE6D0D002 Q40301042-BD698472-2A5C-4BDB-B787-9C5E4D968B92 Q40463082-A16CBB44-20FA-4E57-BA31-009291F5698D Q40488705-1A7C78D4-B837-4AF9-82BE-B4E474141623 Q40983623-B2E2B6B3-171C-4C4A-93FF-584A99A9642C Q41834899-9FD1F608-FD10-43E5-8D32-2F5FDFCF3941 Q42212254-1D2F00C1-EAFD-4451-8EDD-2E6BFBA0279A Q46506090-5C8C456E-8967-49B8-8A7C-43198FC2BE55 Q46666280-0D6D5EF6-CB99-4456-A65E-951BF207BA72 Q50297358-AF27C0C3-FD07-4F8D-A192-5958F970B7BE Q58698930-918EC8E5-5BEB-45A9-B07E-CBA98701F42A

P2860

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

http://www.wikidata.org/entity/Q36371312

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

@ast

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

@en

type

label

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

@ast

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

@en

prefLabel

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

@ast

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

@en

P1433

Q36371312-9FBF5B55-93C2-4F37-94BC-62543036DA9E

P1476

Q36371312-4805FC02-E878-4D8C-A6DC-94A25495A005

P2093

Q36371312-03809568-A330-4171-A27E-CFDC0A3DE88F

Q36371312-57A8A64E-B12C-4EFB-9BFD-AC377BF04FAB

Q36371312-6ECA9B0D-C789-4641-A462-3618DBEB6E83

Q36371312-97B53C08-DE23-4BC9-BA3F-D62891F7F152

Q36371312-C6CD1D79-153D-42E1-B556-CDB2356F68B2

Q36371312-EE605881-64FB-450C-B463-CA1203995F72

P2860

Q36371312-002157FD-2C90-45A6-BB7E-EC0CF16DD39B

Q36371312-05E8E94D-9087-41AE-A248-1165D47988A8

Q36371312-1F558FD6-35C7-45D3-A05E-79C597A3747A

Q36371312-23ACD050-BE84-4F6A-9CE7-871B2A287DC9

Q36371312-24061EC2-35BC-4C5B-BC5C-1555EBB3E14E

Q36371312-24E14D4B-7131-441F-ADFE-BE3FDAA1A7A9

Q36371312-4562F0DB-34B5-4994-A0D6-309F545D996D

Q36371312-49995217-290E-486B-BA9B-51069C71CA76

Q36371312-4A24A16A-25BD-447D-830A-60CFFF4FB041

Q36371312-4FE3CB41-2E9F-48A6-B596-41E453AA96E2

P304

Q36371312-67DC92F0-8264-4922-8FE1-E728F5C1E7D6

P31

Q36371312-8938E74D-6601-457B-93D3-017756F235E6

P356

Q36371312-4B60CDE1-98F2-448E-AFD7-914E66BB229B

P407

Q36371312-AA838261-D4C1-4568-8050-F468E044DE43

P433

Q36371312-CC32512C-A413-4BA0-A630-5B9F8DDEB4FE

P478

Q36371312-481F5ED3-ECE5-4501-834E-8E1E78E96EF0

P50

Q36371312-B8B0A054-50A2-4378-BD49-0167D6E7449D

P577

Q36371312-F3761044-1AC2-4B6E-9735-708E627D5740

P5875

Q36371312-22BF1DD2-20C6-4FC3-8F63-F7391C36037A

P698

Q36371312-EDDC8ACB-3C27-4F91-B1AD-ECF464EDEBE4

P932

Q36371312-476ED116-5F8D-4CEC-A7FF-57E90956B332

P356

P1433

Journal of Experimental Medicine

P1476

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

@en

P2093

Christiane Haefs

http://www.w3.org/2001/XMLSchema#string

Guy S Salvesen

http://www.w3.org/2001/XMLSchema#string

Hamid Kashkar

http://www.w3.org/2001/XMLSchema#string

Hwain Shin

http://www.w3.org/2001/XMLSchema#string

Juliane M Jurgensmeier

http://www.w3.org/2001/XMLSchema#string

Martin Kronke

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

Dimer formation drives the activation of the cell death protease caspase 9

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

Biochemical characteristics of caspases-3, -6, -7, and -8

IAP family proteins--suppressors of apoptosis

Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes

Bax directly induces release of cytochrome c from isolated mitochondria

Two CD95 (APO-1/Fas) signaling pathways

P304

341-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20021279

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

Stephen Hamilton-Dutoit

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10651117

http://www.w3.org/2001/XMLSchema#string

P698

12874265

http://www.w3.org/2001/XMLSchema#string

P932

2194071

http://www.w3.org/2001/XMLSchema#string